These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19809337)

  • 41. Twenty-four months of antipsychotic treatment in children and adolescents with first psychotic episode: discontinuation and tolerability.
    Noguera A; Ballesta P; Baeza I; Arango C; de la Serna E; González-Pinto A; Parellada M; Graell M; Moreno C; Otero S; Castro-Fornieles J
    J Clin Psychopharmacol; 2013 Aug; 33(4):463-71. PubMed ID: 23771198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resolution of risperidone-induced hyperprolactinemia with substitution of quetiapine.
    Kunwar AR; Megna JL
    Ann Pharmacother; 2003 Feb; 37(2):206-8. PubMed ID: 12549948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Self-reported side effects in children and adolescents taking risperidone.
    Byrne S; Walter G; Hunt G; Soh N; Cleary M; Duffy P; Crawford G; Krabman P; Concannon P; Malhi G
    Australas Psychiatry; 2010 Feb; 18(1):42-5. PubMed ID: 20136533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and Safety of Risperidone and Quetiapine in Adolescents With Bipolar II Disorder Comorbid With Conduct Disorder.
    Masi G; Milone A; Stawinoga A; Veltri S; Pisano S
    J Clin Psychopharmacol; 2015 Oct; 35(5):587-90. PubMed ID: 26226481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of Quetiapine and Risperidone in Treatment of Acute Psychosis: A Double-Blind, Randomized-Controlled Study.
    Moosavi SM; Ahmadi M; Mojtahedi D; Yazdani J; Monajemi MB
    Glob J Health Sci; 2015 Jun; 7(5):359-63. PubMed ID: 26156901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Olanzapine compared to quetiapine in adolescents with a first psychotic episode.
    Arango C; Robles O; Parellada M; Fraguas D; Ruiz-Sancho A; Medina O; Zabala A; Bombín I; Moreno D
    Eur Child Adolesc Psychiatry; 2009 Jul; 18(7):418-28. PubMed ID: 19198920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia.
    Kelly DL; Conley RR
    Psychoneuroendocrinology; 2006 Apr; 31(3):340-6. PubMed ID: 16198059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prolactin elevation with ziprasidone.
    Lusskin SI; Cancro R; Chuang L; Jacobson J
    Am J Psychiatry; 2004 Oct; 161(10):1925. PubMed ID: 15465997
    [No Abstract]   [Full Text] [Related]  

  • 49. Risperidone-induced hyperprolactinemia in adolescents: A case series.
    Madhusoodanan S; Moise D
    J Clin Psychiatry; 2006 Jul; 67(7):1110-3. PubMed ID: 16889455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine.
    Kelly DL; Conley RR
    J Clin Psychiatry; 2005 Jan; 66(1):80-4. PubMed ID: 15669892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels.
    Knegtering R; Baselmans P; Castelein S; Bosker F; Bruggeman R; van den Bosch RJ
    Am J Psychiatry; 2005 May; 162(5):1010-2. PubMed ID: 15863810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperprolactinaemia - a risperidone side-effect.
    Grahovac T; Ruzić K; Medved P; Pavesić-Radonja A; Dadić-Hero E
    Psychiatr Danub; 2010 Mar; 22(1):120-2. PubMed ID: 20305606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of a first episode of psychotic illness with quetiapine: an analysis of 2 year outcomes.
    Kopala LC; Good KP; Milliken H; Buiteman C; Woodley H; Rui Q; Whitehorn D; Love L; Balshaw R; Kiss I; Honer WG
    Schizophr Res; 2006 Jan; 81(1):29-39. PubMed ID: 16263246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents.
    Saito E; Correll CU; Gallelli K; McMeniman M; Parikh UH; Malhotra AK; Kafantaris V
    J Child Adolesc Psychopharmacol; 2004; 14(3):350-8. PubMed ID: 15650492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects.
    Roke Y; van Harten PN; Boot AM; Buitelaar JK
    J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):403-14. PubMed ID: 19702492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recommendations on the drug treatment of psychosis in Parkinson's disease.
    Friedman JH
    Am J Med; 2010 Apr; 123(4):e19; author reply e21. PubMed ID: 20362738
    [No Abstract]   [Full Text] [Related]  

  • 57. Quetiapine in the successful combination treatment of an assaultive patient with treatment-resistant schizoaffective disorder.
    Post DE
    Behav Med; 2007; 33(1):11-4. PubMed ID: 17517541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Some effects of risperidone and quetiapine on growth parameters and hormone levels in young pigtail macaques.
    Sackett G; Unis A; Crouthamel B
    J Child Adolesc Psychopharmacol; 2010 Dec; 20(6):489-93. PubMed ID: 21186967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term remission of schizophrenia in an adolescent treated with quetiapine.
    Hayden F
    J Child Adolesc Psychopharmacol; 2001; 11(3):289-93. PubMed ID: 11642479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of symptomatic remission in first-episode psychosis outpatients treated with quetiapine: a naturalistic study.
    Gade K; Köhler J; Klein P; Falkai P; Wobrock T
    Int J Psychiatry Clin Pract; 2013 Jun; 17(2):148-53. PubMed ID: 22746987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.